Remuneration and nomination committee report

Part a:

The chairperson’s statement


Part b:

The forward-looking remuneration policy


Part c:

The implementation of the 2018 remuneration policy


Composition of the committee:

Chairman (remuneration):  
NNA Matyumza

Chairman (nominations):  
ME Mkwanazi (until 26 april 2018)
TP Leeuw (from 26 april 2018)

Other members:
CA Boles
GH Watson

Part a:

 

Dear Shareholders

It is with pleasure that I present to you the remuneration report for the 2018 financial year on behalf of the Remuneration and Nomination Committee (“Remco”). The purpose of this report is to provide the stakeholders with a detailed summary of the organization-wide philosophy and policy pertaining to remuneration at Hulamin Limited (“Hulamin” or the “company”). In accordance with Hulamin’s dedication to being a responsible corporate citizen, this report has been aligned to follow best practice reporting standards incorporating the King IV Report on Corporate Governance (“King IV”) and the Johannesburg Stock Exchange (“JSE”) Listings Requirements.

Despite difficult local and international market conditions, and the volatile South African currency, Hulamin delivered a strong manufacturing performance with best-ever production and sales volumes. In this context, the total STI bonus paid was limited by the business not achieving certain financial performance targets. The 2015 share appreciation right scheme (“SARS”) award scheduled to vest in 2018 did not vest as a result of missing financial performance targets in 2017.

REMCO FOCUS AREAS 2018

In addition to its normal responsibilities, the Remco was faced with challenging policy changes, particularly in relation to the implementation of new corporate governance principles and amended JSE Listings Requirements.

The Remco has obtained the support, advice and opinions of external advisors on various remuneration-related matters. The Remco is satisfied with the constructive, objective and independent advice received.

MANAGEMENT REMUNERATION – A DYNAMIC CONTEXT

Issues around executive remuneration, disparities in pay and transparent disclosure remain topics with widely diverse opinions in South Africa. Cognisant of these issues, the Remco has continued to implement initiatives and policy changes in line with King IV and the JSE Listings Requirements.

With the introduction of the new ECSP in 2018, the previous 2007 schemes (SARS, long-term incentive plan (“LTIP”), and deferred bonus plan (“DBP”)) were discontinued, and no further awards will be made under these old schemes.

In addressing the requirements of the Employment Equity Act 55 of 1998 with regards the principle of equal pay for work of equal value, the Remco has initiated a Fair and Ethical Pay framework. In addition to this, when annual salary increments are applied, adjustments are weighted in favour of employees at lower remuneration levels.

In line with best practice, King IV and the JSE Listings Requirements, we will continue to submit the remuneration policy (part B) and the implementation report (part C) for separate, non-binding advisory votes at AGMs.

SHAREHOLDER ENGAGEMENT

In line with best practice and our value of remuneration being aligned with shareholders and their interests, we regularly engage with shareholders, in 2018 specifically on the design of the revised long-term incentive scheme.

APPRECIATION

The Remco is satisfied that we properly executed our duties in terms of our mandate for FY2018. At the AGM held on 26 April 2018, Hulamin received a 98.55% non-binding advisory vote in favour of both its remuneration policy and implementation report.

We would therefore like to thank our shareholders for their ongoing support as we continually seek to align shareholder interests and remuneration. We at Hulamin and, particularly, the Remco, are steadily continuing on the journey of implementing best practice standards in our remuneration reporting and disclosure.



NNA Matyumza
Chairman of the Remuneration and Nomination Committee

PART B: THE FORWARD-LOOKING REMUNERATION POLICY

The Remco is a subcommittee of the Board of the company (the “Board”) with delegated authority. Hulamin’s remuneration policy is reviewed annually by the Remco and submitted for approval by the Board. The Remco responsibilities and actions are set out and governed in its terms of reference, read together with Hulamin’s remuneration policy and other applicable documents.

The Remco meets at least three times per annum. The Remco members and their meeting attendance record is detailed below:

Member  6 Feb 
Scheduled 
22 Feb 
Special 
14 Jun 
Scheduled 
8 Nov 
Scheduled 
5 Dec 
Special 
NNA Matyumza  ✔  ✔  ✔  ✔  ✔ 
CA Boles  ✔  ✔  ✔  ✔  ✔ 
TP Leeuw (from 26 April 2018) N/A  N/A  ✔  ✔  ✔ 
ME Mkwanazi (to 26 April 2018) ✔  ✔  N/A  N/A  N/A 
GH Watson  ✔  ✔  ✔  ✔  ✔ 


In 2018, scheduled Remco meetings were held on 6 February, 14 June, and 8 November. In addition to the scheduled meetings, Special Remco meetings were held on 22 February and 5 December, shortly before Board meetings, in order to approve recommendations to the board.

Invitees from management who are invited to attend Remco meetings are excused when their respective remuneration is discussed and they also do not take part in any voiting at the Remco meeting.

REMUNERATION PHILOSOPHY

Hulamin’s remuneration philosophy is aligned with the principle of “pay for performance” within the boundaries of the company’s risk appetite, while avoiding the risks associated with undue windfalls or penalisation as a result of factors outside of employees’ locus of control. Variable pay should be only partially affected by the performance of a particular operation in which an employee works where factors outside the employee’s control affect the company’s financial results (e.g. commodity price or currency fluctuations), so as to find a balance between alignment with shareholder interests and employee rewards.

FAIR AND RESPONSIBLE REMUNERATION

The Board, supported by the Remco, gives due consideration to the principle of fair and responsible remuneration. As there are wide ranging opinions on the topic, the Remco reviews and approves initiatives, policies and arrangements to give effect to this principle (in line with best practice and the company’s strategic objectives).

The Remco ensures that executive remuneration (including the remuneration of prescribed officers) is congruent with overall employee remuneration.

The Remco makes recommendations to- and assists the Board in taking the following actions:

In striving to be a responsible corporate citizen, the company continuously considers initiatives to support the principle of fair and responsible remuneration and improve the employment conditions of all employees within the company.

REMUNERATION MIX

Structure of packages

The quantum, structure, composition and mix of remuneration packages supports the company’s strategic objectives, is market related and is aimed at being competitive in the company’s industry. To this end market surveys are conducted annually and used as input where action is required to ensure above principles are applied fairly to all stakeholders.

The appropriate mix between guaranteed and variable pay (including the short- and long-term elements of remuneration) are reviewed by the Remco and the Board from time to time taking market trends into consideration. The Remco ensures that the variable components of remuneration are designed to ensure an appropriate level of risk to the company and its long term objectives, avoiding any possible over-dependence on its variable components.

Note that at lower salary levels, the on-target remuneration mix is weighted towards TGP. and that variable pay constitutes a smaller proportion of total remuneration.

Guaranteed pay (TGP)

Variable pay

Short-Term Incentive Bonus (STI)

The primary purpose of the STI is to serve as a motivator of performance. Refinements to the STI are considered from time-to-time to improve the efficacy of the scheme.

The STI is based on a combination of corporate financial targets, divisional operational targets and individual performance.

Financial performance conditions are based on an equal weighting of Board-approved annual budgets by division:


Operational performance targets are based on the Board-approved annual budget by division:


Individual Key Performance Areas (“KPA”) address the achievement of strategic business objectives across the following general areas:

The STI scheme consists of six different levels. The percentage of TGP payable under the six levels for on-target performance is reflected in the table opposite:

Position  Grade  STI on-target %

of TGP 
STI STRECH %

of TGP 
CEO  FU  60  150 
CFO  FL  50  125 
Other executives  FL  40  100 
Senior management  EU  33  82.5 
Senior management  EL  25  52.6 
Middle management  DU – DL2  15  37.5 
 


In the event of early termination of employment due to resignation or dismissal, there is no entitlement to a bonus payment. In the case of retirement, retrenchment and death in service there is a pro rata entitlement, paid to the participant at the year-end along with other participants.

The payment of bonuses for each component of the respective awards is determined independently from the other components.

The weightings of the targets are as follows:

Position  Grade  Financial

performance 
Operational performance  Safety performance  Individual performance 
CEO  FU  60%  10%  10%  20% 
CFO  FL  50%  20%  10%  20% 
Executives  FL  40%  30%  10%  20% 
Senior management  EU  30%  40%  10%  20% 
Senior management  EL  20%  40%  10%  30% 
Middle management  DU – DL2  10%  40%  10%  40% 


The Remco and the Board have the discretion to decide on the payment or non-payment of performance incentive bonus awards.

Long-Term Incentives
(LTIs – Share Incentive Schemes)

The variable pay component of Hulamin’s remuneration packages is structured to include LTIs for executives and senior management that are market-related and linked to company performance.

The primary purpose of the LTIs is to incentivise employees to achieve the long-term objectives of the company, specifically objectives that have multi-year durations and to retain key talent.

Financial performance conditions are included in order to align with shareholder interests.

Equity-settled Conditional Share Plan (“ECSP”)

The company introduced a new LTI for executives and qualifying management in 2018, being the ECSP.

In line with best practice, regular annual awards of Bonus Shares and Performance Shares are made to ensure long-term shareholder value creation and alignment with acceptable market norms. In addition, the award of Retention Shares is for use in cases where there is a specific need to attract or retain talent.

Annual awards target a market-related level of remuneration whilst considering the overall affordability thereof to the company.

Bonus Shares are not subject to additional performance conditions due to the fact that they have an“entry performance requirement”, where the quantum of the Bonus Shares is determined with reference to the actual STI paid to the participant based on the prior financial year’s performance.

The extent and nature of performance conditions applicable to the Performance Shares awarded in terms of the ECSP are approved by the Remco annually and included in the award letter to participants.

Performance Share awards made to the participants are subject to the following performance conditions, measured over a three-year performance period:

Executives and senior managers may be offered annual LTI awards in terms of the annual allocation levels (as a % of TGP), based on the benchmarks set out below:

Position  Grade  BS as %
of TGP 
PS as %
of TGP 
Total ECSP award value as % of TGP 
CEO  FU  24  36  60 
CFO  FL  20  30  50 
Other executives  FL  16  24  40 
Senior management  EU  13  20  33 
Senior management  EL  10  –  10 
Middle management  DU  – 


Dilution limit applicable to the ECSP

The ECSP is implemented within the shareholder approved dilution limit. The maximum aggregate number of shares that may be acquired by participants may not exceed 15 650 000 shares (5% of issued share capital), with the maximum for any one participant being 3 130 000 shares (1% of issued share capital).

The Remco will review the dilution limit usage and the headroom before an LTI award is made to ensure that the neither the company limit nor the individual limit is exceeded.

Manner of settlement of LTI awards

The rules provide for the following methods of settlement:

The company generally settles the awards through the purchase of shares in the market. The exact method of settlement is determined by the Remco with reference to the dilution limits and the business cycle.

Early termination of employment

Employees may be classified as either a “fault” leaver or a “no-fault” leaver depending on the circumstances whereby their employment is terminated. The provisions below apply to the ESCP as well as the legacy SARs.

The company generally settles the awards through the purchase of shares in the market. The exact method of settlement is determined by the Remco with reference to the dilution limits and the business cycle.

Early termination of employment

Employees may be classified as either a “fault” leaver or a “no-fault” leaver depending on the circumstances whereby their employment is terminated. The provisions below apply to the ESCP as well as the legacy SARs.

Legacy plans

Following the introduction of the ECSP in 2018, there remain a number of residual awards from Hulamin’s legacy plans for the time being – the SARS and the LTIP. No further grants will be made under the legacy plans.

The overall quantum of awards granted under the SARS and/or LTIP was determined by the Remco annually based on the LTI allocation methodology, taking into account relevant market trends, current business issues, and the limits contained in the rules and guidelines of the schemes.

The SARs were offered in the form of performance based conditional awards to eligible executives and senior managers. The performance conditions governing the vesting of the SARs were related to growth in headline earnings per share (relative to targets that were intended to be challenging but achievable), linked, to the company’s medium-term business plan, over three-year performance periods.

Under the LTIP, once-off shares were offered to executives and eligible senior employees in order to attract and retain top talent. These LTIP awards did not bear performance conditions, vested over a three-year period based on tenure and were specifically approved by the Remco.

2015 Employee Share Ownership Plan (“2015 ESOP”)

As Hulamin values its employees as key contributors to the ongoing performance and success of the business, all permanent South African based employees up to middle management (Paterson A band to lower D Band) and all permanent Black South African middle and senior management (Paterson upper D band and above) participate in the 2015 ESOP.

Participation is through two classes of “A” ordinary shares, 15% of which were issued with no strike price (“A1”) and 85% are appreciation rights (“A2”). During the vesting period both classes of share participate in dividends declared by the company. The A1 ordinary shares are entitled to a cash dividend, but for the A2 ordinary shares, the dividend is utilised to reduce the strike price of the right at the time of vesting.

Both classes of shares vest after five years. On vesting, the A1 ordinary shares will convert to Hulamin ordinary shares on a one-for-one basis. The appreciation of the A2 ordinary shares will be converted to Hulamin ordinary shares and the balance of the unvested portion of A2 ordinary shares bought back by the company at a nominal value.

EXECUTIVE CONDITIONS OF EMPLOYMENT

With the exception of notice periods, executives are employed under the same employment conditions as other staff.

The notice period for the CEO is no less than three months and the notice period for other executives is two months. Hulamin reserves the right to terminate an executive’s employment, without notice, for any cause recognised sufficient by law.

Executive employment contracts do not allow for payment of any additional benefits or balloon payments on termination, other than those of other staff employees.

In the event of early termination there is no automatic entitlement to bonuses or share-based incentives. Executives may, however, receive pro rata payment as allowed in terms of the “no-fault” provisions contained in the early termination clauses of the company’s incentive scheme rules.

In terms of executives’ employment contracts there is no automatic severance compensation to executives due to a change of control.
In such cases, the company’s retrenchment policy will apply.

NON-EXECUTIVE DIRECTORS’ (“NEDs”) FEES

NEDs receive fees for serving on the Board and Board committees and do not have service agreements with the company. NED fees are paid in cash on a fixed retainer basis and an attendance fee per meeting. The Board typically holds five Board meetings per year and there are typically three meetings for each of the sub-committees of the Board throughout a financial year.

Attendance at additional sub-committee meetings is remunerated at the standard remuneration rate for attendance at scheduled meetings of such committees. Attendance fees for ad hoc Board committee’s meetings are equivalent to those earned by members of the Remco. Disbursements for reasonable travel and subsistence expenses are reimbursed to NEDs in line with the reimbursement policy for employees.

Fees for NEDs are reviewed on an annual basis taking into account the responsibilities borne by NEDs as well as relevant external market data. Fees are recommended by the Remco and are submitted to the Board for approval, and finally recommended to the shareholders for approval at each AGM.

NEDs are to retain their independence and as such do not receive payments linked to the company’s performance nor do they participate in the company’s incentive schemes.

The proposed fees will be tabled before shareholders for approval by special resolution at the AGM on 25 April 2019:

 

Present fees to
31 July 2019 

Proposed fees from
1 August 2019 

 
Role  Annual
retainer 
Rand 
Attendance per meeting 
Rand 
Annual retainer 
Rand 
Attendance per meeting 
Rand 
%
change  
           
Chairman of the Board  454 680  38 970  477 410  40 920  5.0 
Member of the Board  166 140  14 240  174 450  14 950  5.0 
Chairman of the audit committee  119 570  17 080  125 550  17 930  5.0 
Member of the audit committee  69 480  9 930  72 950  10 430  5.0 
Invitee of the audit committee    9 930    10 430  5.0 
Chairman of the risk and safety, health and environment committee  82 560  11 790  86 690  12 380  5.0 
Member of the risk and safety, health and environment committee  45 310  6 480  47 580  6 800  5.0 
Invitee of the risk and safety, health and environment committee    6 480    6 800  5.0 
Chairman of the Remco  82 560  11 790  86 690  12 380  5.0 
Member of the Remco  45 310  6 480  47 580  6 800  5.0 
Invitee of the Remco    6 480    6 800  5.0 
Chairman of the transformation, social and ethics committee  82 560  11 790  86 690  12 380  5.0 
Member of the transformation, social and ethics committee  45 310  6 480  47 580  6 800  5.0 
Invitee of the transformation, social and ethics committee    6 480    6 800  5.0 
Chairman of an ad hoc Board committee  82 560  11 790  –  12 380  5.0 
Member of an ad hoc Board committee  45 310  6 480  –  6 800  5.0 
Invitee of an ad hoc Board committee    6 480    6 800  5.0 
Fees for international NEDs(€) 30 797  2 638  31 320  2 680  1.6 
Fees for international NEDs ($) 31 163  2 670  31 720  2 720  1.9 

 

VOTING AND SHAREHOLDER ENGAGEMENT

Voting on the remuneration policy and implementation report
In line with best practice, King IV and the JSE Listings Requirements, the remuneration policy and the implementation report (as contained in the annual integrated report) must be tabled for two separate non-binding advisory votes by shareholders at the AGM.

Shareholder engagement
Hulamin is committed to fair, responsible and transparent remuneration and as such invites shareholders to engage with the company on remuneration-related matters.

In the event that 25% or more of the shareholders vote against either or both the remuneration policy, or the implementation report, the Remco will commence engagement with dissenting shareholders and ascertain their reasons and legitimate concerns underlying their votes. In order to do so, the Remco must extend an invitation to dissenting shareholders in the Stock Exchange News Service (“SENS”) announcement together with the results of the AGM, which invitation must include the manner, date and timing of engagement.

PART C:

THE IMPLEMENTATION OF THE 2017 REMUNERATION POLICY

This implementation report is subject to an advisory vote by shareholders at the AGM dated 25 April 2019.

TGP

The Remco approved an average salary increase mandate of 6.4% of cash salary for the executive, and 6.9% increase for other monthly paid employees. The weekly paid and artisan employees are subject to wage negotiations with the bargaining council. The Remco is satisfied that the increase levels for executive directors are in line with increase levels throughout the company.

STI OUTCOMES

The table below sets out the STI performance outcomes for 2018:

Performance measure  Actual
achievement
Financial  71.7 
Operational  88.9 
Safety  50.8 
Individual (average) 96.8 


The table below sets out the STIs the executive directors and prescribed officers were paid for the 2018 financial year, based on the achievement of performance targets, vs their possible STI awards for On-target company performance:

  On-target STI  FY2018 Actual STI 
Participant  Rands  %
of TGP 
Rands  %
of TGP 
RG Jacob (CEO) 3 336 679  60  1 269 239  23 
AP Krull (CFO) 2 069 804  50  933 026  23 
MZ Mkhize
(executive director)
1 581 654  40  1 037 249  26 
DR Weisz1
(prescribed officer)
1 297 729  40  395 764  12 
HT Molale1
(prescribed officer)
1 329 788  40  375 421  11 

1 HT Molale was prescribed officer to 28 February in his capacity as MD of Hulamin Extrusions. From 1 March, DR Weisz assumed the role of prescribed officer when taking over the role of MD of Hulamin Extrusions. Full STI bonus amounts are disclosed.

 

LTI OUTCOMES

The 2015 SARS was due to vest in 2018, and consequently the performance condition was measured over the three-year performance period. The actual 2017 HEPS of 104 cps did not meet the required HEPS target of 137 cps and consequently the 2015 SARS award lapsed.

The 2015 LTIP PC award performance conditions were measured over the three-year performance period. The actual ROCE of 8.9% exceeded the minimum target performance and resulted in 57.5% vesting of the 50% ROCE performance condition. The TSR ranking of Hulamin over the three-year performance period resulted in 44.4% of the 50% TSR performance condition, resulting in a combined 50.96% vesting of the 2015 LTIP PC.

Both the 2015 DBP and LTIP NPC awards were not subject to performance conditions and vested after the three-year tenure condition was satisfied.

Unvested LTIs

The table below discloses the value of each executive director and prescribed officers’ LTIs, whether allocated, settled, or forfeited, as well as the indicative value of awards not yet settled.

  LTI scheme  Date awarded  Vesting date  Opening number  Granted during the year  Grant price Rand  Settled during the year  Lapsed during the year  Closing number  Cash value Rand  Indicative
value
Rand 

Executives 

                     
RG Jacob (CEO) DBP  8 May 15  7 May 18  17 319  –  6.84  17 319      88 327  – 
  SARS  24 Apr 14  23 Apr 17  633 100    6.90  –    633 100    – 
  SARS  23 Apr 15  22 Apr 18  396 925    8.20  –  396 925      – 
  SARS  22 Apr 16  21 Apr 19  744 440    6.30  –    744 440    – 
  SARS  26 Apr 17  25 Apr 20  604 005    6.50  –    604 005    – 
  LTIP PC  23 Apr 15  22 Apr 18  146 625    8.20  146 625      388 544  – 
  LTIP NPC  23 Apr 15  22 Apr 18  48 875    8.20  48 875      254 150  – 
  ECSP – PS  26 Jul 18  25 Jul 21  –  321 279  6.22  –  –  321 279    1 410 415 
  ECSP – BS  26 Jul 18  25 Jul 21  –  117 649  6.22  –  –  117 649    516 479 
AP Krull (CFO) LTIP NPC  1 May 16  30 Apr 19  145 370    5.75  –    145 370    – 
  SARS  26 Apr 17  25 Apr 20  327 554    6.50  –    327 554    – 
  ECSP – PS  26 Jul 18  25 Jul 21  –  199 660  6.22  –  –  199 660    876 507 
  ECSP – BS  26 Jul 18  25 Jul 21  –  78 538  6.22  –  –  78 538    344 782 
MZ Mkhize (Director) SARS  25 May 11  24 May 14  261 503    6.91    261 503      – 
  SARS  25 Feb 13  21 Oct 15  241 172    4.56      241 172    – 
  SARS  24 Apr 14  23 Apr 17  201 780    6.90  –    201 780    – 
  SARS  23 Apr 15  22 Apr 18  138 555    8.20  –  138 555      – 
  SARS  22 Apr 16  21 Apr 19  313 573    6.30  –    313 573    – 
  SARS  26 Apr 17  25 Apr 20  304 817    6.50  –    304 817    – 
  LTIP PC  23 Apr 15  22 Apr 18  61 030    8.20  61 030      161 725  – 
  LTIP NPC  23 Apr 15  22 Apr 18  20 343    8.20  20 343  –    105 784  – 
  ECSP – PS  26 Jul 18  25 Jul 21  –  152 571  6.22  –  –  152 571    669 787 
  ECSP – BS  26 Jul 18  25 Jul 21  –  57 682  6.22  –  –  57 682    172 347 

prescribed officers 

             

HT Molale (MD HulaminExtrusions to28 February)

SARS  24 Apr 14  23 Apr 17  150 157    6.90  –    150 157    – 
SARS  23 Apr 15  22 Apr 18  117 625    8.20  –  117 625  –    – 
SARS  22 Apr 16  21 Apr 19  265 954    6.30  –  25 954  265 954  –   
SARS  26 Apr 17  25 Apr 20  258 285    6.50  –    258 285    – 
  LTIP PC  23 Apr 15  22 Apr 18  51 811    8.20  51 811      133 335  – 
  LTIP NPC  23 Apr 15  22 Apr 18  17 270    8.20  17 270      89 804  – 
  ECSP – PS  26 Jul 18  25 Jul 21  –  128 275  6.22  –  –  128 275    563 127 
  ECSP – BS  26 Jul 18  25 Jul 21  –  52 006  6.22  –  –  52 006    228 306 
  ECSP – RS  26 Jul 18  25 Jul 21  –  133 620  6.22  –  –  133 620    586 592 

DR Weisz (MD HulaminExtrusions from 1 March)

SARS  24 Apr 14  23 Apr 17  170 607    6.90      170 607    – 
SARS  23 Apr 15  22 Apr 18  117 620    8.20  –  117 620  –    – 
SARS  22 Apr 16  21 Apr 19  265 944    6.30  –    265 944    – 
SARS  26 Apr 17  25 Apr 20  258 032    6.50  –    258 032    – 
  LTIP PC  23 Apr 15  22 Apr 18  51 811    8.20  51 809      137 290  – 
  LTIP NPC  23 Apr 15  22 Apr 18  17 270    8.20  17 270      89 804  – 
  ECSP – PS  26 Jul 18  25 Jul 21  –  125 183  6.22  –  –  125 183    549 553 
  ECSP – BS  26 Jul 18  25 Jul 21  –  39 259  6.22  –  –  39 259    172 347 


EXECUTIVE REMUNERATION

The table below sets out the single figure remuneration (i.e. TGP (Basic salary and company contributions), STI and LTI) received by executive directors and prescribed officers in 2018 and 2017, respectively.

  Cash salary
Rands 
Company
contributions
Rands 
STI
Rands 
LTI
Rands 
Total
Rands 
2018           
RG Jacob (executive) 4 821 624  739 508  1 269 239  642 694  7 473 065 
AP Krull (executive) 3 557 424  582 184  933 026  –  5 072 634 
MZ Mkhize (executive) 3 310 776  643 359  1 037 249  267 509  5 258 893 
DR Weisz
(prescribed officer)
2 771 232  473 091  395 764  227 094  3 868 181 
HT Molale
(prescribed officer)
2 787 144  537 325  375 421  227 100  3 926 990 
Total  17 248 200  2 975 468  4 010 699  1 364 397  25 599 763 
2017           
RG Jacob (executive) 4 527 744  684 327  1 939 516  1 609 507  8 806 094 
AP Krull (executive) 3 333 144  545 132  1 281 770  –  5 160 046 
MZ Mkhize (executive) 3 102 228  602 334  943 774  598 066  5 246 402 
HT Molale
(prescribed officer)
2 629 668  505 292  782 612  445 059  4 362 631 
Total  13 592 784  2 337 085  4 947 672  2 652 632  23 575 173 


NED FEES

The table below sets out the fees paid to NEDs in 2018:

Name  Retainer fees
2018
Rands 
Attendance fees
2018
Rands 
Total fees
2018
Rands 
ME Mkwanazi  198 380  108 520  306 900 
TP Leeuw  488 378  195 590  683 968 
VN Khumalo  262 615  144 160  406 775 
AT Nzimande  100 215  25 780  125 995 
NNA Matyumza  329 983  110 280  440 263 
SP Ngwenya  205 022  74 240  279 262 
PH Staude  262 615  89 990  352 605 
GHM Watson  588 799  248 692  837 492 
N Maharajh  297 972  101 370  399 342 
CA Boles  250 437  118 840  369 277 
B Mehlomakulu  209 387  88 080  297 467 
B Larson (note 5) 442 126  189 827  631 953 
Total  3 635 903  1 495 369  5 131 300 


APPROVAL

This report was approved by the Remco on 14 February 2019 and the Board on 28 February 2019. The Remco as well as the Board are satisfied that there were no material deviations from the 2017 remuneration policy during the 2018 financial year.